These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 27717035)

  • 21. Bilateral clicking tinnitus due to myoclonus of middle ear muscles.
    Hornibrook J; Keast A
    N Z Med J; 2019 Mar; 132(1492):67-69. PubMed ID: 30921313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Botulinum toxin treatment of essential palatal myoclonus tinnitus.
    Bryce GE; Morrison MD
    J Otolaryngol; 1998 Aug; 27(4):213-6. PubMed ID: 9711516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation and treatment of synkinesis with botulinum toxin following facial nerve palsy.
    Toffola ED; Furini F; Redaelli C; Prestifilippo E; Bejor M
    Disabil Rehabil; 2010; 32(17):1414-8. PubMed ID: 20156046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Botulinum toxin for aberrant facial nerve regeneration: double-blind, placebo-controlled trial using subjective endpoints.
    Borodic G; Bartley M; Slattery W; Glasscock M; Johnson E; Malazio C; Goodnough M; Acquadro M; McKenna M
    Plast Reconstr Surg; 2005 Jul; 116(1):36-43. PubMed ID: 15988245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SURGICAL ASPECT OF BLEPHAROSPASM TREATMENT: A CASE REPORT.
    Dinjar K; Zubčić V; Kopić A; Kopić V; Popić B; Holik D
    Acta Clin Croat; 2020 Jun; 59(2):377-381. PubMed ID: 33456129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Re: "Botulinum toxin type A for dysthyroid upper eyelid retraction".
    Fay A
    Ophthalmic Plast Reconstr Surg; 2005 Jan; 21(1):81; author reply 81-2. PubMed ID: 15677964
    [No Abstract]   [Full Text] [Related]  

  • 27. Bilateral gustatory sweating in the submandibular region after bilateral neck dissection successfully treated with botulinum toxin.
    Philouze P; Vertu D; Ceruse P
    Br J Oral Maxillofac Surg; 2014 Oct; 52(8):761-3. PubMed ID: 24996697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of aberrant facial nerve regeneration with botulinum toxin A.
    Chua CN; Quhill F; Jones E; Voon LW; Ahad M; Rowson N
    Orbit; 2004 Dec; 23(4):213-8. PubMed ID: 15590522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In reference to Palatal myoclonus: Algorithm for management with botulinum toxin based on clinical disease characteristics.
    Ozdogan F; Genc S; Ozel HE; Esen E; Yüce T; Selcuk A
    Laryngoscope; 2015 Oct; 125(10):E354. PubMed ID: 25877761
    [No Abstract]   [Full Text] [Related]  

  • 30. In response to Palatal myoclonus: Algorithm for management with botulinum toxin based on clinical disease characteristics.
    Sinclair CF; Blitzer A
    Laryngoscope; 2015 Oct; 125(10):E355. PubMed ID: 26152860
    [No Abstract]   [Full Text] [Related]  

  • 31. Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations.
    Bhidayasiri R; Cardoso F; Truong DD
    Eur J Neurol; 2006 Feb; 13 Suppl 1():21-9. PubMed ID: 16417594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paralysis of the orbicularis muscle of the eye using botulinum toxin type A in the treatment for dry eye.
    Serna-Ojeda JC; Nava-Castaneda A
    Acta Ophthalmol; 2017 Mar; 95(2):e132-e137. PubMed ID: 27350144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parry-Romberg syndrome vasculopathy and its treatment with botulinum toxin.
    Borodic GE; Caruso P; Acquadro M; Chick S
    Ophthalmic Plast Reconstr Surg; 2014; 30(1):e22-5. PubMed ID: 23719195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiation-Induced Painful Neurogenic Hypertrophy Treated With Botulinum Toxin A.
    Filippakis A; Ho DT; Small JE; Small KM; Ensrud ER
    J Clin Neuromuscul Dis; 2018 Mar; 19(3):135-137. PubMed ID: 29465614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A review of surgical techniques to correct upper eyelid retraction associated with thyroid eye disease.
    Kazim M; Gold KG
    Curr Opin Ophthalmol; 2011 Sep; 22(5):391-3. PubMed ID: 21730842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Humanistic, utilization, and cost outcomes associated with the use of botulinum toxin for treatment of refractory migraine headaches in a managed care organization.
    Mitchell MP; Schaecher K; Cannon HE; Speckman M
    J Manag Care Pharm; 2008 Jun; 14(5):442-50. PubMed ID: 18597573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of palatal myoclonic tinnitus based on clinical characteristics: a large case series study.
    Park JM; Kim WJ; Han JS; Park SY; Park SN
    Acta Otolaryngol; 2020 Jul; 140(7):553-557. PubMed ID: 32406274
    [No Abstract]   [Full Text] [Related]  

  • 38. [The use of botulinum toxin A in the treatment of focal dystonias].
    Sławek J; Duzyński W
    Neurol Neurochir Pol; 1997; 31(2):207-15. PubMed ID: 9380251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful treatment of autophonia with botulinum toxin: case report.
    Olthoff A; Laskawi R; Kruse E
    Ann Otol Rhinol Laryngol; 2007 Aug; 116(8):594-8. PubMed ID: 17847727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination of blepharospasm and apraxia of eyelid opening: a condition resistant to treatment.
    Rana AQ; Shah R
    Acta Neurol Belg; 2012 Mar; 112(1):95-6. PubMed ID: 22427299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.